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Long-term neurodevelopmental outcome after
intrauterine transfusion for hemolytic disease
of the fetus/newborn: the LOTUS study
Irene T. Lindenburg, MD; Vivianne E. Smits-Wintjens, MD; Jeanine M. van Klink, MSc; Esther Verduin, MD;
Inge L. van Kamp, MD, PhD; Frans J. Walther, MD, PhD; Henk Schonewille, MD, PhD;
Ilias I. Doxiadis, MD, PhD; Humphrey H. Kanhai, MD, PhD; Jan M. van Lith, MD, PhD;
Erik W. van Zwet, MD, PhD; Dick Oepkes, MD, PhD; Anneke Brand, MD, PhD;
Enrico Lopriore, MD, PhD; on behalf of the LOTUS study groupOBJECTIVE: To determine the incidence and risk factors for neurode-
velopmental impairment (NDI) in children with hemolytic disease of the
fetus/newborn treated with intrauterine transfusion (IUT).
STUDY DESIGN: Neurodevelopmental outcome in children at least 2
ears of age was assessed using standardized tests, including the Bay-
ey Scales of Infant Development, the Wechsler Preschool and Primary
cale of Intelligence, and the Wechsler Intelligence Scale for Children,
ccording to the children’s age. Primary outcome was the incidence of
eurodevelopmental impairment defined as at least one of the follow-
ng: cerebral palsy, severe developmental delay, bilateral deafness,
nd/or blindness.
RESULTS: A total of 291 children were evaluated at a median age of 8.2
years (range, 2–17 years). Cerebral palsy was detected in 6 (2.1%) chil-
intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS stud
h
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0002-9378/$36.00 • © 2012 Mosby, Inc. All rights reserved. • doi: 10.1016dren, severe developmental delay in 9 (3.1%) children, and bilateral
deafness in 3 (1.0%) children. The overall incidence of neurodevelop-
mental impairment was 4.8% (14/291). In a multivariate regression
analysis including only preoperative risk factors, severe hydrops was in-
dependently associated with neurodevelopmental impairment (odds ra-
tio, 11.2; 95% confidence interval, 1.7–92.7).
CONCLUSION: Incidence of neurodevelopmental impairment in chil-
dren treated with intrauterine transfusion for fetal alloimmune anemia is
low (4.8%). Prevention of fetal hydrops, the strongest preoperative pre-
dictor for impaired neurodevelopment, by timely detection, referral and
treatment may improve long-term outcome.
Key words: hemolytic disease of the fetus/newborn, intrauterine
transfusion, neurodevelopmental outcome, red cell alloimmunizationCite this article as: Lindenburg IT, Smits-Wintjens VE, van Klink JM, et al; on behalf of the LOTUS study group. Long-term neurodevelopmental outcome after
y. Am J Obstet Gynecol 2012;206:141.e1-8.
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oFetal and neonatal hemolytic diseaseresults from maternal alloimmuni-
zation to red cell antigens, for which
mother and fetus are incompatible. Ma-
ternal immunoglobulin gamma (IgG)
antibodies pass the placenta into the fetal
circulation and cause destruction of fetal
red cells. The resulting progressive fe-
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FEBRUARY 2012 Americostnatal and more recently antenatal
nti-D prophylaxis programs,3,4 im-
proved diagnostic management and
neonatal treatment.1,5-7 One of the ma-
or advances was the introduction in
963 of intrauterine blood transfusions
IUTs),1 first performed by Liley using
he intraperitoneal technique.8 In the
980s, this technique was replaced by
he intravascular IUT.1 Nowadays, this
treatment is the most successful proce-
dure in fetal therapy, with perinatal sur-
vival rates exceeding 95% in experienced
centers.1,7 However, one of the concerns
f the more widespread and successful
se of fetal therapy is that a decrease in
erinatal mortality may lead to an in-
rease of children with long-term hand-
caps. Only a few studies with small
atient numbers have reported on long-
erm neurodevelopmental outcome
fter IUT, with an incidence of adverse
utcome ranging from 4.5 to 12%.9-16enb
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Research Obstetrics www.AJOG.orgthe incidence and risk factors for adverse
neurodevelopmental outcome after IUT
treatment in the largest cohort of chil-
dren worldwide.
MATERIALS AND METHODS
In 2008, we designed a large national
cohort study to evaluate the long-term
neurodevelopmental outcome in chil-
dren treated with IUT: the LOTUS study
(LOng-Term follow-up after intra-Uter-
ine transfusionS).17 All mothers with red
ell alloimmunization treated with IUT
etween Jan. 1, 1988, and Jan. 1, 2008, at
he Leiden University Medical Center
nd their children were invited to partic-
pate in this large follow-up study. For
he purpose of this study, we included all
hildren of 2 to 17 years of age who had
omplete follow-up, including a cogni-
ive development test. Children with se-
ere congenital anomalies and syndro-
al disorders were excluded. This study
as approved by the ethics committee of
he Leiden University Medical Center.
nformed consent was obtained from all
articipating families. A limited out-
ome evaluation in a small part of our
tudy group (11 children treated be-
ween 1991 and 1993) was described be-
ore.9 Primary outcome was a composite
utcome termed neurodevelopmental
mpairment (NDI) defined as at least 1 of
he following; cerebral palsy (CP), severe
ognitive developmental delay ( 2
tandard deviation [SD]), bilateral deaf-
ess requiring hearing amplification,
nd/or bilateral blindness.
The Leiden UniversityMedical Center
erves as the single national reference
enter for the management of red cell al-
oimmunization in pregnancy in the
etherlands. IUTs are performed when
igns of fetal anemia are detected on
oppler ultrasound examinations. De-
ails on our management guidelines for
lloimmunized pregnancies were previ-
usly described.18 Because the imple-
entation of the IUT program using the
ltrasound-guided intravascular trans-
usion technique at our center in 1987,
ll relevant perinatal data have prospec-
ively been collected in a computerized
atabase. Data included are as follows:
ype of alloimmunization, gestational a
141.e2 American Journal of Obstetrics& Gynecologe at IUT, hemoglobin level, presence
nd severity of hydrops at the start of the
ntrauterine treatment, number of IUTs,
estational age at birth, sex, birthweight,
nd neonatal outcome. Neonatal out-
ome data included: number of ex-
hange transfusions because of severe
yperbilirubinemia, respiratory distress
yndrome, necrotizing enterocolitis
classified according to Bell et al19),
epsis (defined as clinical symptomsof in-
ection and a positive bacterial blood cul-
ure) and severe cerebral injury detected
itheroncranialultrasound, computed to-
ography scan (CT), or magnetic reso-
ance imaging (MRI). Severe cerebral in-
ury was defined as the presence of
ntraventricular hemorrhage  grade 3
classified according to Volpe20), cystic
eriventricular leukomalacia  grade
(classified according to deVries et al21),
nd/or ventricular dilatation (defined
ccording to Levene22). Other major ce-
ebral abnormalities associated with ad-
erse neurologic outcome were also re-
orded and classified as severe cerebral
esions. We recorded the presence of
erinatal asphyxia, defined as 3 or more
f the following 5 criteria: nonreassuring
ardiotocogram patterns, umbilical cord
rterial pH 7.10, Apgar score 5 at 5
inutes after birth, failure of spontane-
us breathing at 5 minutes after birth,
nd onset of multiple organ failure.
Parental education was determined by
he level of education of each parent in-
ividually. A score of 1 was given if the
arent’s education was low, a score of 2
or an average educational level, and a
core of 3 for higher levels of education.
ducation scores of both parents were
hen added (score range from 2 to 6).
thnicity was recorded as white or non-
hite. Children were considered to
e white when 1 or both parent(s) were
f white ethnicity.
Follow-up
All participating families visited our out-
patients clinic from August 2008 to No-
vember 2010. At this visit, a physical and
neurologic examination according to
Touwen et al23 and an assessment of cog-
nitive development using standardized
tests were performed.17 All childrenwere
ssessed by 1 of the 3 investigators spe-
gy FEBRUARY 2012ialized in developmental assessment
I.L., V.S., and E.L.).
Presence of CP was assessed according
o the criteria of the European CP Net-
ork and classified as diplegia, hemiple-
ia, quadriplegia, dyskinetic, ormixed.24
Minor neurologic dysfunction (MND)
was defined as a moderate abnormality
of tone, posture, and movement leading
to only minor functional impairment or
minor developmental delay.23
Cognitive development in children
aged 2 to 3 years was assessed according
to the Dutch version of the Bayley Scales
of Infant Development, 2nd edition
(BSID-II).17 BSID-II scores provide a
ental developmental index (MDI).
hildren between 3 and 7 years of age
ere tested with theDutch version of the
echsler Preschool andPrimary Scale of
ntelligence, 3rd edition (WPPSI-III-
L).17 Cognitive development in chil-
dren between 7 and 17 years of age was
assessed with the Dutch version of the
Wechsler Intelligence Scale for Children,
3rd edition (WISC-III-NL).17 Both the
WPPSI and theWISC provide a full scale
IQ score. BSID-MDI,WPPSI, andWISC
scores follow a normal distribution
curve with a mean score of 100. A score
of 70-84 indicates mild delay (ie,  1
SD) and a score70 indicates severe de-
lay (ie,2 SD). A trained psychologist
(J.K.), blinded to the antenatal course
and neonatal outcome, performed the
tests in all children.
Risk factors
Potential risk factors forNDIwere inves-
tigated including severity of fetal anemia
(actual hemoglobin level and Z-hemo-
globin), presence, and severity of fetal
hydrops (classified according to van
Kamp et al25) at start of the intrauterine
treatment, number of IUTs, gestational
age at birth (divided into 3 groups: neo-
nates born before 32 weeks’ gestation,
between 32 and 35 weeks’ gestation, and
after 35 weeks’ gestation), severe neona-
tal morbidity, and perinatal asphyxia.
StandardizedZ scores of hemoglobin (Z-
hemoglobin) were defined as the num-
ber of SDs that an actual value deviated
from the normal mean for gestational
age. Reference values for hemoglobin
were derived from the literature.26 Se-
P
c
I
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www.AJOG.org Obstetrics Researchvere neonatal morbidity was defined as
the presence of 1 or more of the follow-
ing: respiratory distress syndrome, ne-
crotizing enterocolitis grade 2, sepsis,
and/or severe cerebral injury.
Statistical analyses
We used univariate logistic regressions
to test the association between NDI and
the potential risk factors.We entered the
risk factors into amultivariate logistic re-
gression model and included additional
potential confounders, including sex,
parental education, and ethnicity. Mul-
tiple logistic regression analysis was used
to measure the independent effect of the
potential risk factors for NDI. Results of
logistic regression were considered sig-
nificant at P values  .05. We used the
earson correlation test to calculate the
orrelation between hemoglobin at first
UT and IQ score. Analyses were per-
ormed using SPSS version 16 (SPSS Inc,
hicago, IL).
RESULTS
During the study period 1284 IUTs were
performed in 451 fetuses. Thirty-one fe-
tuses died in utero and 11 in the neonatal
period resulting in a perinatal survival
rate of 91% (409/451). Two more chil-
dren died during childhood because of
causes unrelated to hemolytic disease of
the fetus/newborn (1 accidental infant
death occurred because of incorrect con-
struction of the bedframe and 1 infant
death was due to acute cardiomyopathy
and pulmonary hypertension). Thus, the
overall survival rate was 90% (407/451).
Three children were diagnosed with
congenital anomalies, including Kins-
bourne’s syndrome, congenital cerebel-
lar hypoplasia, and Phelan-McDermid
syndrome and were excluded from fur-
ther analysis. A total of 342 childrenwere
2 to 17 years of age and thus eligible for
the study. Fifty-one (15%) children were
lost-to-follow-up because of declined
consent (6%, 21/342) or loss of contact
address (9%, 30/342). Complete fol-
low-up data were obtained from 291
children by a visit at our outpatient
clinic. A flowchart showing the deriva-
tion of our study population is shown in
Figure 1.Perinatal outcome
Detailed information on the baseline
perinatal characteristics on 291 long-
term survivors is summarized in Table 1.
The mean hemoglobin level at first IUT
was 5.5 g/dL ( 2.4 SD), and the Z-he-
moglobin 7.3 SDs. Both the mean he-
moglobin level and Z-hemoglobin in fe-
tuses with hydrops (mild or severe) were
significantly lower than in fetuses with-
out hydrops, 3.3 vs 6.3 g/dL (P  .001)
and9.1 vs6.7 (P .001).
The percentage of neonates born 32
weeks’, between 32 and 35 weeks’, and
35 weeks’ gestation was 2% (6/291),
15.5% (45/291), and 82.5% (240/291).
Exchange transfusions during the
neonatal period were performed in 58%
(168/291) of children. The following se-
FIGURE 1
Flowchart showing the derivation o
Fet
Appr
Children 2-17 years o
n = 342 (85%) 
Participation 
n = 291 (85%) 
Death 
n = 44 (10%) 
Lindenburg. Long-term outcome fetal transfusions. Am J Obsvere neonatal morbidities were recorded:
FEBRUARY 2012 Americrespiratory distress syndrome (2.4%,
7/291), necrotizing enterocolitis (1.0%,
3/291), sepsis (5.8%, 17/291), perinatal
asphyxia (3.8%, 11/291), and severe ce-
rebral injury (1.7%, 5/291). Severe cere-
bral injury detected on cranial ultra-
sound included ventricular dilatation
(n  2), hemorrhagic periventricular
leukomalacia (n  1), cystic periven-
tricular leukomalacia (n 1), and exten-
sive cerebral abscess (n  1). In both
children with ventricular dilatation, ce-
rebral abnormalities were already de-
tected antenatally. The incidence of
severe neonatal morbidity was signifi-
cantly higher in the group neonates born
before 32 weeks’ gestation (odds ratio
[OR], 32.1; 95% confidence interval
[CI], 5.4 –190.8; P  .001). No signifi-
ur study population
s treated with IUT 
n = 451 
hed for participation 
n = 404 
Children > 17 years old 
n = 62 (15%) 
st-to-follow-up 
 = 51 (15%) 
Severe congenital anomalies
n = 3 (1%) 
ynecol 2012.f o
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Research Obstetrics www.AJOG.orgnatal characteristics were found be-
tween the follow-up (n  291) and
ost-to-follow-up group (n  51).
Long-term neurodevelopmental
outcome
The median age at follow-up was 8.2
years (range, 2–17 years). The incidence
of CP was 2.1% (6/291) (spastic quadri-
plegia: n 3, spastic diplegia: n 2, dys-
inetic: n  1). MND was recorded in
1.0% (32/291). None of the children
ad kernicterus. Nineteen children were
valuated using BSID-II tests, the aver-
geMDI score was 93 14. A total of 89
hildren were tested using the WPPSI
nd 183were tested using theWISC. The
verage full scale IQ in theWPPSI-group
nd WISC-group was 100  14.8 and
01  13.5, respectively. We found no
orrelation between hemoglobin level at
rst IUT and full scale IQ score (r 0.1,
P .1) (Figure 2). Severe developmental
elay ( 2 SD) was detected in 3.1%
9/291) of children. Moderate develop-
ental delay (1 SD) was detected in
4.4% (42/291) of children. Bilateral
eafness was present in 3 children
1.0%). None of the children had bilat-
ral blindness. Table 2 summarizes the
long-termneurodevelopmental outcome.
Overall, the incidence of NDI (CP,
TABLE 1
Baseline characteristics
Characteristic
Rhesus D alloimmunization, n (%)
...................................................................................................................
Kell, n (%)
...................................................................................................................
Rhesus c, n (%)
...................................................................................................................
Other, n (%)
...................................................................................................................
Gestational age at first IUT, wksa
...................................................................................................................
Number of IUTs per fetusa
...................................................................................................................
Hemoglobin at first IUT, g/dLa
...................................................................................................................
Hydrops, n/N (%)
..........................................................................................................
Mild hydrops, n/N (%)
..........................................................................................................
Severe hydrops, n/N (%)
...................................................................................................................
Gestational age at birth, wksb
...................................................................................................................
Birthweight, gb
...................................................................................................................
Neonates requiring an exchange transfusion,
...................................................................................................................
a Values are given in mean 1 SD (range); b Value given in m
Lindenburg. Long-term outcome fetal transfusions. Am Jsevere developmental delay, deafness,
141.e4 American Journal of Obstetrics& Gynecoloand/or blindness) was 4.8% (14/291).
Details on the combinations of abnor-
mal findings in the children with adverse
outcome are presented in Table 3. One
infant with CP (no. 14 in Table 3) had no
cranial ultrasound examination in the
neonatal period, but aMRI performed at
2 years of age showed signs of cerebral
atrophia, suggestive for periventricular
leukomalacia. One infant with severe ce-
rebral injury detected on ultrasound and
MRI (hemorrhagic periventricular leu-
komalacia) in the neonatal period had a
favorable outcome. Another infant with
extensive bacillus cereus cerebral abscess
had also a favorable outcome and was
previously reported.27
The incidence ofNDIwas significantly
higher in children with a history of mild
and severe hydrops. Mild hydrops was
present in 36% (5/14) of children with
NDI compared with 18% (49/277) of
children without NDI (OR, 4.3; 95% CI,
1.2–15.3; P .025). Severe hydrops was
present in 29% (4/14) of children with
NDI comparedwith 6% (17/277) of chil-
dren without NDI (OR, 9.9; 95% CI,
2.4–40.5; P .001).
The risk of NDI was significantly in-
creased in the group of neonates born
prematurely (gestational age at birth
Value
233 (80)
..................................................................................................................
36 (12)
..................................................................................................................
15 (5)
..................................................................................................................
6 (2)
..................................................................................................................
26  4.2 (16–35)
..................................................................................................................
3  1.1 (1–6)
..................................................................................................................
5.5  2.4 (1.1–13.2)
..................................................................................................................
75/291 (26)
..................................................................................................................
54/75 (72)
..................................................................................................................
21/75 (28)
..................................................................................................................
36 (35–37)
..................................................................................................................
2812 (2520–3159)
..................................................................................................................
) 168 (58)
..................................................................................................................
n and interquartile range.
et Gynecol 2012.32weeks) (OR, 12.8; 95%CI, 2.1–79.5; N
gy FEBRUARY 2012P  .006) (Table 4), but was not in-
creased in the group of neonates born
between 32 and 35 weeks (OR, 1.8; 95%
CI, 0.5–7.0; P  .38) and 35 weeks’
gestation (OR, 0.4; 95% CI, 0.1–1.3;
P .08).
Univariate analysis of potential risk
factors forNDIwas performed (Table 4).
Several risk factors were found to be as-
sociated with NDI, including fetal hy-
drops, hemoglobin level, number of
IUTs, prematurity, and severe neonatal
morbidity.
We found no difference between the
groups with and without NDI for sex
57% (8/14 male) vs 55% (151/277 male)
(P .85) and ethnicity (white) 14% (2/
4) vs 6% (18/277) (P .24). Mean pa-
ental education was significantly lower
n theNDI group comparedwith the no-
DI group 3.2 1.1 vs 4.2 1.4, respec-
ively (P  .016). Post hoc analysis
howed no difference in the incidence of
xchange transfusion between the group
ith (57%, 8/14) and without NDI
58%, 160/277) (P .96).
Potential risk factors and the possible
onfounder parental education were en-
ered in amultivariate logistic regression
odel to assess the independent associ-
tion with NDI (Table 4). We excluded
emoglobin at first IUT from this multi-
ariate analysis model, as this variable is
trongly associated with the presence of
ydrops and could possibly bias our re-
ults. In a multivariate regression ana-
ysis, including prenatal and postnatal
actors, the following risk factors were
ndependently associated with NDI:
umber of performed IUTs (OR, 2.3 per
UT; 95% CI, 1.1–4.6; P  .02), severe
eonatal morbidity (OR, 85.6; 95% CI,
.7–755.3; P  .001), and parental edu-
ation (OR, 8.4; 95% CI, 2.2–31.5; P 
002).
To determine the predictive role of
renatal risk factors, we entered the fol-
owing factors in a separate multivariate
egression model by using only the fol-
owing prenatal factors: mild hydrops,
evere hydrops, level of hemoglobin at
rst IUT, and number of IUTs. We
ound that only severe hydrops (OR,
1.2; 95% CI, 1.7–92.7; P  .011) was
ignificantly independent associated with.........
.........
.........
.........
.........
.........
.........
.........
.........
.........
.........
.........
n (%
.........
ediaDI.
t
i
w
e
w
p
g
e
p
h
a
w
p
t
f
s
l
o
f
k
p
www.AJOG.org Obstetrics ResearchCOMMENT
This is the largest study to date on long-
term neurodevelopmental outcome in
children surviving a high-risk pregnancy
thanks to invasive fetal therapy. The vast
majority (over 95%) of children treated
with IUT for severe fetal anemia had a
normal neurodevelopmental outcome.
The incidence of severe developmental
delay (3.1%) was in line with the Dutch
normative population (2.3%).28 In addi-
ion, the incidence of bilateral deafness
n the general population was similar to
hat we found in our cohort.29 How-
ver, the rate of CP (2.1%) in our study
as higher compared with the general
opulation (0.7% at 32 to 36 weeks’
estation30 and 0.2% at 37 weeks’
gestation31).
A few small studies on the long-term
neurodevelopmental outcome in chil-
dren treated with IUT have been repor-
ted.9-16 The 2 largest studies to date re-
veal higher incidences of NDI when
compared with our results, 10% (7/69)
and 8% (3/38), respectively.9,10 Differ-
nces in long-term outcome may be ex-
lained bymethodologic differences and
eterogeneity between the studies.
Apart from the reassuring results valu-
ble for counseling pregnant women
ith red cell alloimmunization, the im-
ortance of our analysis lies in the iden-
ification of potentially avoidable risk
actors for adverse outcome. The current
tudy shows a clear association with
ong-term impairment and the presence
f hydrops and number of IUTs per-
ormed. Severe fetal hydrops was already
nown to be associated with increased
erinatal mortality.25 The underlying
mechanism causing cerebral damage
and long-term NDI in hydropic and se-
verely anemic fetuses is not yet known.
Cerebral lesionsmay result fromhypoxic
injury related to severe anemia. Because
short- and long-term outcome appears
to be better in nonhydropic fetuses, cli-
nicians should try to prevent or reduce
the development of hydrops in fetuses at
risk for fetal anemia. Interestingly, the
actual hemoglobin concentration was
more strongly associated with NDI than
the hemoglobin z-score. This concurs
with the concept that tissue oxygenationdepends more closely to the number of
circulating red cells than on deviation of
the hemoglobin level from the mean for
gestational age. Whether more timely
detection and treatment of fetal anemia,
and prevention of hydrops improves
outcome, and what degree of anemia ac-
tually requires transfusion needs further
study.
FIGURE 2
Relation between hemoglobin level
At first IUT and full scale IQ score, in children wi
IQ, intelligence quotient; IUT, intrauterine blood transfusions.
Lindenburg. Long-term outcome fetal transfusions. Am J Obs
TABLE 2
Long-term neurodevelopmental ou
survivors after intrauterine transfu
Variable
Age at follow-up, ya
...................................................................................................................
Isolated severe development delay, n (%)
...................................................................................................................
Isolated cerebral palsy, n (%)
...................................................................................................................
Isolated bilateral deafness, n (%)
...................................................................................................................
Cerebral palsy and severe developmental dela
...................................................................................................................
Neurodevelopmental impairment,a n (%)
...................................................................................................................
a Neurodevelopmental impairment is defined as at least one of
SD), bilateral deafness, or blindness.Lindenburg. Long-term outcome fetal transfusions. Am J Obst
FEBRUARY 2012 AmericAnother risk factor for NDI was severe
neonatal morbidity. As shown in our re-
sults, both the incidenceof severeneonatal
morbidity and the incidence of NDI were
associatedwith the severityofprematurity.
Severe prematurity is a well-known risk
factor for neonatal morbidity, cerebral in-
jury, and long-term adverse outcome.32,33
We did not find a relation between NDI
ed dots) and without (blue dots) fetal hydrops.
ynecol 2012.
me in 291 long-term
ns
8.2 (2-17)
..................................................................................................................
5 (1.7)
..................................................................................................................
2 (0.7)
..................................................................................................................
3 (1.0)
..................................................................................................................
(%) 4 (1.4)
..................................................................................................................
14 (4.8)
..................................................................................................................
llowing: cerebral palsy, severe development delay (2s
th (r
tet Gtco
sio
.........
.........
.........
.........
y, n
.........
.........
the foet Gynecol 2012.
an Journal of Obstetrics& Gynecology 141.e5
Obst
Research Obstetrics www.AJOG.organd exchange transfusions, which we in-
terpretasconfirmationofourrelativelyag-
gressive neonatal management protocol
aimed at reducing the rate of severe hyper-
bilirubinemia. None of the children had
kernicterus.
TABLE 3
Data of 14 long-term survivors afte
alloimmune anemia with neurodev
Case Hydrops
Hemoglobin,
g/dL
(GA at IUT-wk)
Number
of IUT
1 none 5.3 (33) 1
...................................................................................................................
2 none 7.9 (26) 2
...................................................................................................................
3 mild 3.9 (28) 3
...................................................................................................................
4 mild 3.2 (24) 3
...................................................................................................................
5 none 5.6 (22) 4
...................................................................................................................
6 none 5.5 (24) 4
...................................................................................................................
7 severe 3.1 (26) 4
...................................................................................................................
8 severe 2.4 (26) 4
...................................................................................................................
9 severe 4.2 (22) 4
...................................................................................................................
10 mild 4.7 (26) 4
...................................................................................................................
11 mild 1.5 (19) 5
...................................................................................................................
12 mild 2.6 (21) 5
...................................................................................................................
13 none 6.8 (21) 5
...................................................................................................................
14 severe 1.9 (18) 5
...................................................................................................................
GA, gestational age; IUT, intrauterine transfusion; NEC, necro
Lindenburg. Long-term outcome fetal transfusions. Am J
TABLE 4
Analysis of potential risk factors fo
Variable
NDI
(n  14)
Hydrops, n (%) 9 (64)
...................................................................................................................
Hemoglobin at first IUT,b g/dL 4.2  1.9
...................................................................................................................
Z hemoglobin (SDs) 8.1
...................................................................................................................
Number of IUTsc 4 (1–5)
...................................................................................................................
GA at birth 32 wks, n (%) 2 (14)
...................................................................................................................
Perinatal asphyxia, n (%) 1 (7)
...................................................................................................................
Severe neonatal morbidity,d
n (%)
6 (43)
...................................................................................................................
GA, gestational age; IUT, intrauterine transfusion; OR, odds ra
a Including parental education as a possible confounder; b Val
distress syndrome, intraventricular hemorrhage grade 3,Lindenburg. Long-term outcome fetal transfusions. Am J Obst
141.e6 American Journal of Obstetrics& GynecoloFinally, parental education was inde-
pendently associated with NDI. Socio-
economic status (SES) and parental
educational level are well known deter-
minants of child cognitive develop-
ment.28,34-37 Both factors may influence
ntrauterine transfusions for fetal
pmental impairment
A at
irth,
k
Birthweight,
g
Severe
neonatal
morbidity
Age at
follow
y
5 2580 sepsis, asphyxia 8
.........................................................................................................................
9 1460 PVL II, NEC III B 12.5
.........................................................................................................................
3 3100 None 10
.........................................................................................................................
0 1700 RDS 8
.........................................................................................................................
5 3020 None 2
.........................................................................................................................
6 2750 None 8
.........................................................................................................................
5 2526 None 15
.........................................................................................................................
5 2835 ventricular
dilatation
13.5
.........................................................................................................................
5 2460 ventricular
dilatation
9.5
.........................................................................................................................
4 3200 sepsis 10
.........................................................................................................................
7 3310 none 5
.........................................................................................................................
4 1915 none 2
.........................................................................................................................
8 2800 none 4.5
.........................................................................................................................
6 3035 none 14
.........................................................................................................................
enterocolitis; PVL, periventricular leukomalacia; RDS, respiratory
et Gynecol 2012.
eurodevelopmental impairment (NDI
P value
NDI
 277)
univariate
analysis
OR (95% CI)
univariate analysis
(24) .002 5.8 (1.9–17.8)
.........................................................................................................................
.6  2.4 .032 1.3 per g/dL decrease
.........................................................................................................................
.3 .13 1.3 per SD decrease (0
.........................................................................................................................
(1–6) .018 1.7 per IUT (1.1–2.5)
.........................................................................................................................
(1) .006 12.8 (2.1–79.5)
.........................................................................................................................
(4) .51 2.0 (0.2–17.1)
.........................................................................................................................
(6)  .001 13.1 (4.0–42.4)
.........................................................................................................................
D, standard deviation.
ven as meanSD; c Value given as median (range); d Severe neo
entricular leukomalacia grade 2, necrotizing enterocolitis get Gynecol 2012.
gy FEBRUARY 2012child cognitive functioning for a variety
of reasons, including reduced access to
essentialmaterial resources (such as cog-
nitively stimulating materials) and/or
nonmaterial resources (such as educa-
tion, information, and skills). Moreover,
, Bilateral
deafness
Cerebral
palsy
Severe
developmental
delay
No diplegia No
..................................................................................................................
No quadriplegia Yes
..................................................................................................................
Yes no No
..................................................................................................................
Yes no No
..................................................................................................................
No no Yes
..................................................................................................................
No no Yes
..................................................................................................................
No no Yes
..................................................................................................................
No diplegia No
..................................................................................................................
No quadriplegia Yes
..................................................................................................................
Yes no No
..................................................................................................................
No no Yes
..................................................................................................................
No dyskinetic Yes
..................................................................................................................
No no Yes
..................................................................................................................
No quadriplegia Yes
..................................................................................................................
ess syndrome.
P value OR (95% CI)
multivariate
analysisa
multivariate
analysisa
.11 3.3 (0.76–14.5)
..................................................................................................................
–1.7) — —
..................................................................................................................
1.1) — —
..................................................................................................................
.02 2.3 per IUT (1.1–4.6)
..................................................................................................................
.54 2.3 (0.17–31.1)
..................................................................................................................
.19 5.8 (0.4–81.3)
..................................................................................................................
 .001 85.6 (9.7–755.3)
..................................................................................................................
l morbidity is defined as at least 1 of the following: respiratory
2, and sepsis.r i
elo
G
b
w
-up
3
......... .........
2
......... .........
3
......... .........
3
......... .........
3
......... .........
3
......... .........
3
......... .........
3
......... .........
3
......... .........
3
......... .........
3
......... .........
3
......... .........
3
......... .........
3
......... .........
tizing distrr n )
No
(n
66
......... .........
5 (1.0
......... .........
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......... .........
3
......... .........
4
......... .........
10
......... .........
16
......... .........
tio; S
ue gi nata
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o
b
f
e
w
www.AJOG.org Obstetrics Researchgenetic conditionsmay account for up to
72% of the variance in intelligence.38
The 2 most important limitations of
our study were the relatively incomplete
follow-up and the lack of a control
group. We were not able to trace 9% of
children, mainly because of the long
time-lap since IUT treatment. In addi-
tion, 6% of families declined to partici-
pate to the study. The risk for an adverse
outcome has been shown to be higher in
the lost-to-follow group as children at
increased risk for severe neurodevelop-
mental compromise may not return for
evaluation.39 Nevertheless, comparisons
f antenatal and perinatal characteristics
etween the study group and the lost-to-
ollow-up showed no significant differ-
nces, suggesting that this type of bias
as limited.
CONCLUSIONS
The high rate of intact survival in this
high-risk group of severely anemic fe-
tuses confirms the success of this antena-
tal treatment. Although hemolytic dis-
ease of the fetus/newborn was the main
cause of perinatal death for many years,
the chance of successful recovery with
adequate antenatal management can
nowadays be considered as excellent.
However, several factors were associated
with increased risk for NDI, including
fetal hydrops, number of IUTs, and se-
vere neonatal morbidity. Future studies
to reduce the incidence of these risk fac-
tors in children treated with IUT may
help decrease the rate of adverse long-
term outcome. f
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